Literature DB >> 25790961

Association between hypouricemia and reduced kidney function: a cross-sectional population-based study in Japan.

Minako Wakasugi1, Junichiro James Kazama, Ichiei Narita, Tsuneo Konta, Shouichi Fujimoto, Kunitoshi Iseki, Toshiki Moriyama, Kunihiro Yamagata, Kazuhiko Tsuruya, Koichi Asahi, Kenjiro Kimura, Masahide Kondo, Issei Kurahashi, Yasuo Ohashi, Tsuyoshi Watanabe.   

Abstract

BACKGROUND: Hypouricemia, conventionally defined as a serum uric acid level of ≤2 mg/dl, is considered a biochemical disorder with no clinical significance. However, individuals with renal hypouricemia have a high risk of urolithiasis and exercise-induced acute kidney injury, both of which are risk factors for reduced kidney function.
METHODS: To test the hypothesis that individuals with hypouricemia would be at a higher risk of reduced kidney function, we conducted a population-based cross-sectional study using data from the Specific Health Checkups and Guidance System in Japan. Logistic analysis was used to examine the relationship between hypouricemia and reduced kidney function, defined as estimated glomerular filtration rate <60 ml/min/1.73 m(2).
RESULTS: Among 90,710 men (mean age, 63.8 years) and 136,935 women (63.7 years), 193 (0.2%) and 540 (0.4%) were identified as having hypouricemia, respectively. The prevalence of hypouricemia decreased with age in women (p for trend <0.001), but not in men (p for trend = 0.24). Hypouricemia was associated with reduced kidney function in men (odds ratio, 1.83; 95% confidence interval, 1.23-2.74), but not in women (0.61; 0.43-0.86), relative to the reference category (i.e., serum uric acid levels of 4.1-5.0 mg/dl) after adjusting for age, drinking, smoking, diabetes, hypertension, hypercholesterolemia, obesity, and history of renal failure. Sensitivity analyses stratified by diabetic status yielded similar results.
CONCLUSIONS: This study is the first to provide evidence that hypouricemia is associated with reduced kidney function in men. Further research will be needed to determine the long-term prognosis of individuals with hypouricemia.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25790961     DOI: 10.1159/000381106

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  23 in total

1.  Intensive uric acid-lowering therapy in CKD patients: the protocol for a randomized controlled trial.

Authors:  Masato Kasahara; Yoshihiro Kuwabara; Toshiki Moriyama; Kazuaki Tanabe; Noriko Satoh-Asahara; Tomohiro Katsuya; Shinya Hiramitsu; Hidetaka Shimada; Tosiya Sato; Yoshihiko Saito; Takahiko Nakagawa
Journal:  Clin Exp Nephrol       Date:  2019-11-15       Impact factor: 2.801

2.  Temporal trends in the prevalence and characteristics of hypouricaemia: a descriptive study of medical check-up and administrative claims data.

Authors:  Ruriko Koto; Izumi Sato; Masanari Kuwabara; Tomotsugu Seki; Koji Kawakami
Journal:  Clin Rheumatol       Date:  2022-01-24       Impact factor: 2.980

Review 3.  Renal hypouricemia in a recipient of living-donor kidney transplantation: a case report and literature review.

Authors:  Takamasa Miyauchi; Maho Terashita; Masatomo Ogata; Marie Murata; Kiyomi Osako; Naohiko Imai; Yuko Sakurai; Hideo Sasaki; Yuki Ohashi; Kimiyoshi Ichida; Yugo Shibagaki; Masahiko Yazawa
Journal:  CEN Case Rep       Date:  2021-09-23

4.  Serum Uric Acid Levels and Nephrosclerosis in a Population-Based Autopsy Study: The Hisayama Study.

Authors:  Kenji Maki; Jun Hata; Satoko Sakata; Emi Oishi; Yoshihiko Furuta; Toshiaki Nakano; Yoshinao Oda; Takanari Kitazono; Toshiharu Ninomiya
Journal:  Am J Nephrol       Date:  2022-02-01       Impact factor: 3.754

5.  Prevalence and complications of hypouricemia in a general population: A large-scale cross-sectional study in Japan.

Authors:  Masanari Kuwabara; Koichiro Niwa; Akira Ohtahara; Toshihiro Hamada; Satoshi Miyazaki; Einosuke Mizuta; Kazuhide Ogino; Ichiro Hisatome
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

Review 6.  Sex Differences in Urate Handling.

Authors:  Victoria L Halperin Kuhns; Owen M Woodward
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

7.  Association between post-transplant serum uric acid levels and kidney transplantation outcomes.

Authors:  Deok Gie Kim; Hoon Young Choi; Ha Yan Kim; Eun Ju Lee; Kyu Ha Huh; Myoung Soo Kim; Chung Mo Nam; Beom Seok Kim; Yu Seun Kim
Journal:  PLoS One       Date:  2018-12-14       Impact factor: 3.240

8.  Distribution and Characteristics of Hypouricemia within the Japanese General Population: A Cross-Sectional Study.

Authors:  Shin Kawasoe; Kazuki Ide; Tomoko Usui; Takuro Kubozono; Shiro Yoshifuku; Hironori Miyahara; Shigeho Maenohara; Mitsuru Ohishi; Koji Kawakami
Journal:  Medicina (Kaunas)       Date:  2019-03-04       Impact factor: 2.430

9.  Independent association of plasma xanthine oxidoreductase activity with hypertension in nondiabetic subjects not using medication.

Authors:  Masato Furuhashi; Yukimura Higashiura; Masayuki Koyama; Marenao Tanaka; Takayo Murase; Takashi Nakamura; Seigo Akari; Akiko Sakai; Kazuma Mori; Hirofumi Ohnishi; Shigeyuki Saitoh; Kazuaki Shimamoto; Tetsuji Miura
Journal:  Hypertens Res       Date:  2021-06-11       Impact factor: 3.872

Review 10.  Physiology of Hyperuricemia and Urate-Lowering Treatments.

Authors:  Caroline L Benn; Pinky Dua; Rachel Gurrell; Peter Loudon; Andrew Pike; R Ian Storer; Ciara Vangjeli
Journal:  Front Med (Lausanne)       Date:  2018-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.